New pill shows promise for ulcerative colitis sufferers

NCT ID NCT05570006

Completed Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jan 08, 2026 · Last updated May 14, 2026 · Updated 24 times

Summary

This study tested an experimental drug called ABBV-668 in 30 adults with moderate to severe ulcerative colitis, a condition causing inflammation and bleeding in the colon. Participants took the drug twice daily for 16 weeks. The goal was to see if it could improve colon healing and reduce symptoms, while monitoring side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Allegheny Singer Research Institute d/b/a AHN Research Institute /ID# 250079

Pittsburgh, Pennsylvania, 15212, United States
Atlantic Medical Research /ID# 249213

Margate, Florida, 33063-5737, United States
Atrium Health /ID# 249273

Charlotte, North Carolina, 28204-2963, United States
Baylor College of Medicine /ID# 249203

Houston, Texas, 77030, United States
CHU Grenoble - Hopital Michallon /ID# 252108

La Tronche, Isere, 38700, France
CHU Montpellier - Hopital Saint Eloi /ID# 251876

Montpellier, Herault, 34295, France
Centre Hospitalier Universitaire de Saint Étienne - Hôpital Nord /ID# 251875

St-Priest-en-Jarez, Pays de la Loire Region, 42270, France
Centre Medico Chirurgical Ambroise Pare Hartmann /ID# 252357

Neuilly-sur-Seine, Île-de-France Region, 92200, France
Columbia University Medical Center /ID# 250189

New York, New York, 10032-3729, United States
Ctr for Advanced Gastroenterol /ID# 249226

Maitland, Florida, 32751-6108, United States
Digestive Health Associates of Texas (DHAT) Research Institute - Garland /ID# 249208

Garland, Texas, 75044, United States
Endoscopic Research, Inc. /ID# 249202

Orlando, Florida, 32803, United States
Endoskopia Sp. z o.o. /ID# 255667

Sopot, Pomeranian Voivodeship, 81-756, Poland
Gastro SB /ID# 249271

Chula Vista, California, 91910-5619, United States
Gastroenterology Associates of Central Georgia, LLC /ID# 249278

Macon, Georgia, 31201, United States
Gastroenterology Associates, P.A. of Greenville /ID# 249217

Greenville, South Carolina, 29607, United States
Gastromed Sp. z o.o /ID# 255664

Torun, Kuyavian-Pomeranian Voivodeship, 87-100, Poland
Groupe Sante CHC - Clinique du MontLegia /ID# 248928

Liège, 4000, Belgium
H-T Centrum Medyczne Endoterapia /ID# 255666

Tychy, Silesian Voivodeship, 43-100, Poland
Lenox Hill Hospital /ID# 250008

New York, New York, 10075, United States
Medical Network Sp.z.o.o. WIP Warsaw IBD Point Profesor Kierkus /ID# 255663

Warsaw, Masovian Voivodeship, 00-728, Poland
NYU Langone Long Island Clinical Research Associates /ID# 250075

Lake Success, New York, 11042, United States
Options Health Research, LLC /ID# 249216

Tulsa, Oklahoma, 74104, United States
Quality Medical Research /ID# 251125

Nashville, Tennessee, 37211, United States
Southern Star Research Institute, LLC /ID# 249212

San Antonio, Texas, 78229-5390, United States
UZ Gent /ID# 248605

Ghent, Oost-Vlaanderen, 9000, Belgium
Universitair Ziekenhuis Leuven /ID# 248598

Leuven, Vlaams-Brabant, 3000, Belgium
University of Pennsylvania /ID# 250012

Philadelphia, Pennsylvania, 19104-5502, United States
University of Pittsburgh MC /ID# 250071

Pittsburgh, Pennsylvania, 15260, United States
Vitaz /Id# 248607

Sint-Niklaas, Oost-Vlaanderen, 9100, Belgium

Conditions

Explore the condition pages connected to this study.

ULCERATIVE COLITIS ULCERATIVE COLITIS